Papers
2
Total Citations
14
H-Index
2
About
Kevin Wang is a leading surgical oncologist whose research centers on the treatment of oropharyngeal and salivary gland malignancies, with a particular focus on the application and outcomes of transoral robotic surgery (TORS). His major contributions include landmark national-level analyses that have reshaped clinical decision-making for rare head and neck cancers. In his most-cited work, "National Analysis of Oropharyngeal Salivary Gland Malignancies Treated With Transoral Robotic Surgery" (2021, 9 citations), Wang systematically compared perioperative outcomes and overall survival between TORS and conventional approaches, identifying key clinical factors that favor a robotic surgical strategy. He further advanced the field with his study on "National analysis of positive surgical margins in oropharyngeal salivary gland malignancies" (2022, 5 citations), which provided critical insights into surgical precision and prognostic indicators. Wang’s work is notable for leveraging large-scale national databases to generate evidence-based guidelines for these complex tumors, directly impacting surgical planning and patient counseling. His research bridges the gap between innovative technology and clinical practice, making him a key voice in the evolution of minimally invasive head and neck surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2